MedTrace Logo

A Study to Compare the Pharmacokinetic Characteristics of CJ-12420

NCT02995239 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2016-12-16

No results posted yet for this study

Summary

To compare the pharmacokinetics after administration of different formulation of CJ-12420

Conditions

  • Erosive Esophagitis

Interventions

DRUG

CJ-12420 formulation 2

CJ-12420 formulation 2

DRUG

CJ-12420 formulation 1

CJ-12420 formulation 1

Sponsors & Collaborators

  • HK inno.N Corporation

    lead INDUSTRY

Principal Investigators

  • Min-Gul Kim, MD · Chonbuk university hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02995239 on ClinicalTrials.gov